FERGUSON STRATEGIES, LLC for CELGENE CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Policy issues relating the U.S.-China Joint Commission on Commerce and Trade, including Article 26.3 of Chinese Patent Law and biopharmaceutical intellectual property.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
Health Issues HCR
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program; policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act"; H.R. 3116, the "Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act"; and policy issues relating to orphan drugs and medicines for rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.